Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Coronavirus disease - COVID-19 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
2 Coronavirus disease - COVID-19 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
3 Coronavirus disease - COVID-19 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
4 Cytokine-cytokine receptor interaction 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
5 Cytokine-cytokine receptor interaction 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
6 Cytokine-cytokine receptor interaction 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
7 EGFR tyrosine kinase inhibitor resistance 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
8 EGFR tyrosine kinase inhibitor resistance 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
9 EGFR tyrosine kinase inhibitor resistance 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
10 Hematopoietic cell lineage 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
11 Hematopoietic cell lineage 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
12 Hematopoietic cell lineage 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
13 HIF-1 signaling pathway 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
14 HIF-1 signaling pathway 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
15 HIF-1 signaling pathway 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
16 Human cytomegalovirus infection 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
17 Human cytomegalovirus infection 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
18 Human cytomegalovirus infection 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
19 JAK-STAT signaling pathway 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
20 JAK-STAT signaling pathway 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
21 JAK-STAT signaling pathway 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
22 Non-alcoholic fatty liver disease 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
23 Non-alcoholic fatty liver disease 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
24 Non-alcoholic fatty liver disease 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
25 Pathways in cancer 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
26 Pathways in cancer 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
27 Pathways in cancer 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
28 PI3K-Akt signaling pathway 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
29 PI3K-Akt signaling pathway 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
30 PI3K-Akt signaling pathway 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
31 Th17 cell differentiation 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
32 Th17 cell differentiation 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
33 Th17 cell differentiation 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
34 Viral protein interaction with cytokine and cytokine receptor 💬
1件: IL6R 💬 Sarilumab 💬 Sarilumab 5件: 41, 46, 84, 107, 271 💬
35 Viral protein interaction with cytokine and cytokine receptor 💬
1件: IL6R 💬 Satralizumab 💬 Satralizumab 3件: 11, 13, 86 💬
36 Viral protein interaction with cytokine and cytokine receptor 💬
1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 21件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬